CTSG
CTSG (cathepsin G, also known as CG) is a peptidase S1 family serine protease found in the azurophil granules of neutrophils. It has chymotrypsin-like specificity and contributes to antimicrobial defence and connective tissue remodelling during inflammation. Browse Assay Genie's current range of CTSG research reagents below, or read on for the biology behind the target.
CTSG is a serine protease of the peptidase S1 family, classified as EC 3.4.21.20. It is found in the azurophil granules of neutrophilic polymorphonuclear leukocytes, and its specificity is similar to that of chymotrypsin C. The enzyme is thought to take part in the killing and digestion of engulfed pathogens, and in connective tissue remodelling at sites of inflammation.
The protein is also directly antimicrobial, with bacteriocidal activity reported against S. aureus and N. gonorrhoeae. Pathogens have evolved countermeasures: the S. aureus serine protease inhibitors Eap, EapH1 and EapH2 reversibly inhibit cathepsin G and impair microbicidal activity in neutrophils. UniProt records the protein in several compartments, including cytoplasmic granules, the cell membrane, the secreted fraction, cytosol, lysosome and nucleus.
The CTSG gene encodes a protein of the peptidase S1 family, and transcript variants that use alternative polyadenylation signals exist. HGNC places it in the groups Cathepsins, Receptor ligands, Granule associated serine proteases of immune defence, and Elastases. The CTSG gene has orthologues named Ctsg in both mouse and rat, which allows its biology to be studied in rodent models. Researchers studying neutrophil function, innate immunity and protease-driven tissue remodelling will find CTSG a useful target, and CTSG antibody or CTSG ELISA kit approaches are common routes to measuring it.
CTSG is a characteristic component of azurophil granules in neutrophilic polymorphonuclear leukocytes, making it relevant to granule content and neutrophil function.
The protease may help kill and digest engulfed pathogens and shows bacteriocidal activity against S. aureus and N. gonorrhoeae.
CTSG may contribute to connective tissue remodelling at sites of inflammation, linking protease activity to tissue turnover.
S. aureus inhibitors Eap, EapH1 and EapH2 reversibly inhibit cathepsin G, providing a model of bacterial evasion of neutrophil killing.
CTSG is a chymotrypsin-like serine protease stored in neutrophil azurophil granules. It may participate in killing and digesting engulfed pathogens and in connective tissue remodelling at inflammatory sites. It is also antimicrobial, with bacteriocidal activity against S. aureus and N. gonorrhoeae.
CTSG is the HGNC symbol for cathepsin G, and CG is a recorded alias. HGNC lists no previous names. The enzyme is classified as EC 3.4.21.20, and the NCBI Gene summary notes that transcript variants using alternative polyadenylation signals exist.
Yes. Mouse and rat both have an orthologue named Ctsg. Cross-species work should consider sequence differences, so check the datasheet of any product for its validated reactivity.
Other neutrophil granule proteases, cathepsins and innate immune markers with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P08311; product specifications from Assay Genie datasheets.